ALDAMA PHARMACEUTICALS Trademark
ALDAMA PHARMACEUTICALS is a USPTO trademark filed by Aldama Pharmaceuticals, Inc.. Status: Pending.
Trademark Facts
| Mark | ALDAMA PHARMACEUTICALS |
|---|---|
| Serial Number | 99266049 |
| Status | Pending |
| Filing Date | 2025-07-03 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Aldama Pharmaceuticals, Inc. |
| Attorney of Record | Eric T. Fingerhut |
| Prosecution Events | 32 |
| Latest Event | AMPB on 2026-05-04 |
Goods & Services
Class 005: Dietary supplements; Pharmaceutical preparations for the treatment of a wide variety of diseases, conditions and disorders, namely, infectious diseases, cardiovascular diseases, respiratory diseases, gastrointestinal diseases, metabolic and endocrine disorders, neurological diseases and disorders, psychiatric and mental health disorders, namely, anxiety disorder, depression disorder, substance use disorder, post-traumatic stress disorder, and bipolar disorder, autoimmune and inflammatory diseases, musculoskeletal disorders, dermatological diseases, oncological diseases, hematological disorders, renal and urological diseases, hepatic diseases, ophthalmic diseases, otic diseases, allergic diseases, immunological disorders, pain and pain related conditions, namely, chronic low back pain, osteoarthritis, migraine and chronic headache disorders, fibromyalgia, and neuropathic pain, sleep disorders, reproductive and sexual health disorders, hormonal disorders, nutritional deficiencies, genetic disorders, namely, down syndrome, Klinefelter syndrome, cystic fibrosis, sickle cell disease and Marfan syndrome, and chronic and acute medical conditions, namely, hypertension, type 2 diabetes, asthma, acute myocardial infarction, and pneumonia; Class 040: Custom manufacture of pharmaceuticals
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-28 | Drawing | DRW |
| 2026-04-28 | Preliminary Amendment | PRA |
| 2026-04-24 | Amendment and Mail Process Complete | AMC |
| 2026-04-24 | Final Action | FREF |
| 2026-04-24 | Public Note | PNR |
| 2026-04-24 | Examiner's Amendment | EXAMA |
USPTO Refusals on Record
- indefinite_identification